Clinical Approach to Genetic Cardiomyopathy in Children

Ovid Technologies (Wolters Kluwer Health) - Tập 94 Số 8 - Trang 2021-2038 - 1996
Marcy L. Schwartz1, Gerald F. Cox1, Angela E. Lin1, Mark Korson1, Antonio R. Pérez‐Atayde1, Ronald V. Lacro1, Steven E. Lipshultz1
1the Department of Cardiology (M.L.S., R.V.L., S.E.L.), Division of Genetics, Inborn Errors of Metabolism Service, Department of Medicine (G.F.C., M.S.K.), and Department of Pathology (A.P.-A.), Children's Hospital, Boston, Mass; and Department of Pediatrics (M.L.S., G.F.C., M.S.K., R.V.L., S.E.L.) and Department of Pathology (A.P.-A.), Harvard Medical School, Boston, Mass.

Tóm tắt

Background Cardiomyopathy (CM) remains one of the leading cardiac causes of death in children, although in the majority of cases, the cause is unknown. To have an impact on morbidity and mortality, attention must shift to etiology-specific treatments. The diagnostic evaluation of children with CM of genetic origin is complicated by the large number of rare genetic causes, the broad range of clinical presentations, and the array of specialized diagnostic tests and biochemical assays. Methods and Results We present a multidisciplinary diagnostic approach to pediatric CM of genetic etiology. We specify criteria for abnormal left ventricular systolic performance and structure that suggest CM based on established normal echocardiographic measurements and list other indications to consider an evaluation for CM. We provide a differential diagnosis of genetic conditions associated with CM, classified as inborn errors of metabolism, malformation syndromes, neuromuscular diseases, and familial isolated CM disorders. A diagnostic strategy is offered that is based on the clinical presentation: biochemical abnormalities, encephalopathy, dysmorphic features or multiple malformations, neuromuscular disease, apparently isolated CM, and pathological specimen findings. Adjunctive treatment measures are recommended for severely ill patients in whom a metabolic cause of CM is suspected. A protocol is provided for the evaluation of moribund patients. Conclusions In summary, we hope to assist pediatric cardiologists and other subspecialists in the evaluation of children with CM for a possible genetic cause using a presentation-based approach. This should increase the percentage of children with CM for whom a diagnosis can be established, with important implications for treatment, prognosis, and genetic counseling.

Từ khóa


Tài liệu tham khảo

10.1536/ihj.31.789

10.1016/0002-9149(91)90833-7

10.1016/S0735-1097(85)80319-3

Kumar K, Thatai D, Saxena A, Srinivas V, Juneja R, Kothari SS, Shrivastava S, Lipshultz SE. Pediatric dilated cardiomyopathy (DCM): prognosis in a developing nation is comparable to developed nations. J Am Coll Cardiol. 1996;27:187A. Abstract.

10.1006/bmmb.1993.1032

10.1056/NEJM199403313301308

10.1007/BF02429041

Servidei S, Bertini E, DiMauro S. Hereditary metabolic cardiomyopathies. Adv Pediatr. 1994;41:1-32.

Pierpont ME Moller JH. Cardiac manifestations of genetic disease. In: Emmanouilides GC Riemenschneider TA Allen HD Gutgesell HP eds. Moss and Adams Heart Disease in Infants Children and Adolescents. 5th ed. Baltimore Md: Williams & Wilkins; 1995;2:1486-1520.

10.1161/circ.64.3.7196300

10.1016/0167-5273(91)90117-8

10.1161/circ.93.5.841

10.1016/S0140-6736(57)90159-9

10.1136/bmj.1.5219.69

Perloff JK. Cardiomyopathies in infants and children. In: Moss AJ ed. Pediatrics Update: Reviews for Physicians. New York NY: Elsevier Science Publishing Co; 1985:187-204.

10.1016/S0735-1097(10)80282-7

10.1016/S0022-3476(94)70008-7

10.1016/0002-9149(76)90433-1

Gussenhoven WJ, Busch HFM, Kleijer WJ, deVilleneuve VH. Echocardiographic features in the cardiac type of glycogen storage disease II. Eur Heart J. 1983;4:41-43.

10.7326/0003-4819-116-11-896

10.1136/hrt.34.8.862

10.1016/S0022-3476(87)80341-4

10.1016/S0046-8177(85)80071-X

10.1016/S0022-3476(88)80535-3

10.1016/0887-8994(89)90012-X

10.1212/WNL.37.6.1065

10.1161/circ.52.4.808361

10.1016/0002-9149(76)90468-9

10.1016/0002-9149(88)91325-2

10.1016/S0022-3476(05)80441-X

10.1007/BF02281012

Vervoort R, Islam MR, Sly WS, Zabot MT, Kleijer WJ, Chabas A, Fensom A, Young EP, Liebaers I, Lissens W. Molecular analysis of patients with β-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII. Am J Hum Genet. 1996;58:457-471.

10.1056/NEJM198210073071505

10.1536/ihj.35.635

Millaire A, Warembourg A, Leys D, Tison E, Tondeux S, De Groote P, Ketelers JY, Fourrier F, Petit H, Ducloux G. La maladie de Refsum: a propos de deux cas reveles par une myocardiopathie. Ann Cardiol Angeio (Paris). 1990;39:173-178.

10.1016/S0022-3476(85)80472-8

10.1007/BF00442086

10.1016/0002-9149(74)90097-6

10.1007/BF01800221

10.1016/0002-9343(91)80091-Y

10.1016/S0022-3476(82)80295-3

10.1172/JCI113066

Reichmann H, Angelini C. Single muscle fibre analyses in 2 brothers with succinate dehydrogenase deficiency. Eur Neurol. 1993;34:95-98.

Papadimitriou A, Neustein HB, DiMauro S, Stanton R, Bresolin N. Histiocytoid cardiomyopathy of infancy: deficiency of reducible cytochrome b in heart mitochondria. Pediatr Res. 1984;18:1023-1028.

10.1007/BF00313387

10.1001/archneur.1986.00520110084025

10.1203/00006450-199212000-00022

10.1002/ajmg.1320500310

10.1161/circ.91.4.955

10.1007/BF00795646

10.1016/S0006-291X(05)80773-9

10.1002/humu.1380030107

Merante F, Tein I, Benson L, Robinson BH. Maternally inherited hypertrophic cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA (glycine) gene. Am J Hum Genet. 1994;55:437-446.

10.1136/hrt.59.4.486

10.1212/WNL.41.7.1053

10.1016/S0022-3476(05)80289-6

10.1016/0022-510X(92)90195-Q

Servidei S, Dionisi-Vici C, Bertini E. Sengers disease with deficiency of complexes I and IV. Ital J Neurol Sci. 1990;11:194. Abstract.

10.1016/0002-9394(86)90402-2

10.1016/0960-8966(93)90039-M

10.1016/0735-1097(88)90296-3

10.1056/NEJM198108133050707

10.1136/adc.62.11.1170

10.1002/mus.880130303

10.1056/NEJM199112263252607

10.1056/NEJM199207023270104

10.1203/00006450-199307000-00025

10.1542/peds.87.3.328

10.1203/00006450-199012000-00023

10.1002/ana.410300315

Niederwieser A, Steinmann B, Exner U, Neuheiser F, Redweik U, Wang M, Rampini S, Wendel U. Multiple acyl-CoA dehydrogenase deficiency (MADD) in a boy with non-ketotic hypoglycemia, hepatomegaly, muscle hypotonia, and cardiomyopathy: detection of N-isovalerylglutaric acid and its monoamide. Helv Pediatr Acta. 1983;38:9-26.

10.1007/BF01955907

Thompson GN Danks DM Edis DB. Cardiomyopathy as a complication of methylmalonic acidemia. In: Proceedings of the 28th SSIEM annual symposium; 1993:43; Birmingham UK. Abstract.

10.1007/BF00711684

10.1016/S0022-3476(81)80404-0

10.1542/peds.91.5.915

Edwards MA, Green A, Colli A, Rylance G. Tyrosinaemia type I and hypertrophic obstructive cardiomyopathy. Lancet. 1987;1:1437-1438.

Allanson J. Noonan syndrome. J Pediatr. 1987;24:9-13.

10.1002/ajmg.1320450407

10.1002/ajmg.1320390323

10.1007/BF02076346

St. John Sutton MG, Tajik AJ, Giuliani ER, Gordon H, Su WP. Hypertrophic obstructive cardiomyopathy and lentiginosis: a little known neural ectodermal syndrome. Am J Cardiol. 1981;47:215-217.

Lin AE, Garver KL. Cardiac abnormalities in neurofibromatosis. Neurofibromatosis. 1988;1:146-151.

Greenwood RD, Sommer A, Rosenthal A, Craenen J, Nadas AS. Cardiovascular abnormalities in the Beckwith-Wiedemann syndrome. Am J Dis Child. 1977;131:293-294.

10.1007/BF02083298

Chitayat D, Meuneir C, Hortop J, Beland M, Pinsky L, Zaor S, Der Kaloustian V, Robb L, Weksberg R. Lethal hypertrophic cardiomyopathy in one of two half-sibs with Beckwith-Wiedemann syndrome. Proc Greenwood Genet Ctr. 1993;12:91-92.

Brunner HG, Kapusta L. Familial cardiomyopathy, telecanthus and associated anomalies. Proc Greenwood Genet Ctr. 1990;9:94. Abstract.

10.1093/oxfordjournals.eurheartj.a062313

Stevens CA, Bhakta MG. Cardiac abnormalities in the Rubenstein-Taybi syndrome. Proc Greenwood Genet Ctr. 1994;13:113. Abstract.

10.1002/ajmg.1320440320

10.1136/jmg.28.9.619

10.1136/hrt.56.4.321

10.1016/S0022-3476(86)80389-4

10.1002/ajmg.1320620203

Johnson JP, Fries MH, Norton ME, Rosenblatt R, Feldman G, Yang S, Golabi M. Prenatal overgrowth with postnatal growth failure, dysmorphic facies, cutaneous features and cardiomyopathy: overlap of amicable, facio-cutaneous-skeletal (FCS), and Costello (CS) syndromes. Proc Greenwood Genet Ctr. 1993;12:98. Abstract.

Coffin GS. Developmental retardation with unusual facies, arthritis, and hearing impairment. Dysmorph Clin Genet. 1990;4:103-109.

10.1111/j.1399-0004.1977.tb01339.x

10.1111/j.1399-0004.1984.tb01073.x

10.1016/S0022-3476(96)70394-3

10.1002/ajmg.1320450302

10.1002/jor.1100020406

10.1136/bjo.73.4.250

Char F, Readinger RI, McConnell JR, McCoy JR. A new (?) X-linked connective tissue disorder with joint hyperextensibility, mild cutis laxa, skeletal anomalies and idiopathic hypertrophic subaortic stenosis. Proc Greenwood Genet Ctr. 1987;6:174-177.

10.1002/ajmg.1320530205

10.1002/ajmg.1320300131

10.1002/ajmg.1320230107

10.1002/ajmg.1320130108

Fryns JP, Chrzanowska K, Van den Berghe H. Hypohidrotic ectodermal dysplasia, primary hypothyroidism, and agenesis of the corpus callosum. J Med Genet. 1989;26:520-534.

10.1002/ajmg.1320050309

10.1378/chest.87.1.56

10.1002/ajmg.1320370219

10.1016/0002-8703(88)90484-X

10.7326/0003-4819-93-6-813

Morris CA. Unknown case: mental retardation craniosynostosis multiple congenital anomalies hypertrophic cardiomyopathy. Presented at the David W. Smith Workshop on Malformations and Morphogenesis; August 1993; Mount Tremblant Quebec Canada.

10.1002/ajmg.1320460209

10.1016/0306-9877(93)90206-6

10.1093/oxfordjournals.eurheartj.a060343

10.1016/0022-510X(92)90073-T

10.1056/NEJM199602083340604

10.1136/hrt.63.2.119

10.1038/ng1294-323

10.1055/s-2008-1052404

Hoshio A, Kotake H, Saito M, Ogino K, Fujimoto Y, Hasegawa J, Kosaka T, Mashiba H. Cardiac involvement in patients with limb-girdle muscular dystrophy. Heart Lung. 1987;16:439-441.

10.1016/0387-7604(94)90027-2

10.1136/hrt.38.5.504

10.1016/0046-8177(90)90078-J

10.1016/0887-8994(88)90071-9

10.1007/BF02072073

Magliocco AM, Mitchell LB, Brownell AKW, Lester WM. Dilated cardiomyopathy in multicore myopathy. Am J Cardiol. 1988;63:150-151.

10.1136/adc.59.3.217

10.1093/oxfordjournals.eurheartj.a060072

10.1161/circ.91.2.532

Solomon SD, Geisterfer-Lowrance AAT, Vosberg HP, Hiller G, Jarcho JA, Morton CC, McBride WO, Mitchell AL, Bale AE, McKenna WJ, Seidman JG, Seidman CE. A locus for familial hypertrophic cardiomyopathy is closely linked to the cardiac myosin heavy chain genes, CRI-L436, and CRI-L329 on chromosome 14 at q11-q12. Am J Hum Genet. 1990;47:389-394.

10.1056/NEJM199204233261703

10.1056/NEJM199504203321603

10.1038/ng1295-434

MacRae C Ghaisas N McGarry K McKenna W Seidman JG Seidman CE. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. Circulation. 1994;90(pt 2):I-M. Abstract.

10.1016/0735-1097(94)90640-8

10.1038/ng0894-546

10.1016/0002-8703(92)90814-C

10.4065/70.7.634

10.1016/0002-8703(80)90234-3

10.1016/0046-8177(92)90410-5

10.1093/hmg/3.6.959

10.1161/circ.82.2.2372897

10.1056/NEJM199309233291304

10.1056/NEJM198705073161904

10.1161/circ.87.6.8504498

Mestroni L, Krajinovic M, Serverini GM, Falaschi A, Giacca M, Camerini F. Molecular genetics of dilated cardiomyopathy. Herz. 1994;19:97-104.

10.1016/0167-5273(85)90352-3

10.1378/chest.71.5.677

10.1161/circ.52.6.126823

Verlos A, LeMerrer M, Soyeur D. Cardio-facial-cutaneous syndrome: a syndrome distinct from Noonan syndrome. Ann Genet. 1988;31:230-234.

10.1038/ng1294-357

10.1161/circ.57.6.639232

10.1136/hrt.20.3.416

10.1016/0002-9343(67)90017-4

10.1136/hrt.59.1.47

10.1093/nar/16.23.11141

10.1007/BF00205170

10.1212/WNL.43.11.2342

10.2169/internalmedicine.32.408

10.1212/WNL.39.8.1011

10.1056/NEJM198805263182104

10.1002/clc.4960100209

10.1016/0002-9149(79)90160-7

10.1161/circ.67.6.6682724

10.1016/0002-9149(81)90068-0

10.1016/0002-9149(79)90388-6

10.1161/circ.71.1.4038370

10.1161/circ.79.3.2917389

10.1016/1058-9813(92)90025-H

10.1016/0002-9149(84)90643-X

10.1161/circ.89.1.8281650

10.1056/NEJM198703263161305

10.1136/adc.59.10.971

10.1016/S0033-0620(05)80036-2

10.1056/NEJM199201093260201

10.1002/ajmg.1320560207

10.1136/jmg.30.11.955

10.1136/hrt.72.4.344

10.1016/0140-6736(92)92942-9

10.1016/1058-9813(92)90028-K

10.1007/BF00794836

10.1016/S0735-1097(88)80024-X

10.1016/S0735-1097(10)80074-9

10.1161/circ.90.3.8087940

10.1136/hrt.47.6.527

10.1016/0002-9149(77)90157-6

10.1056/NEJM197701202960303

10.1172/JCI113978

10.1007/BF01955069

10.1007/BF01812853

10.1016/S0022-3476(05)81661-0

Roth B, Younossi-Hartenstein A, Skopnik H, Leonard JV, Lehnert W. Haemodialysis for metabolic decompensation in propionic acidemia. J Inherit Metab Dis. 1987;10:147-151.

10.1016/S0031-3955(16)38877-0

10.1097/00008480-199312000-00016

10.1146/annurev.ph.56.030194.003555

10.1007/BF01963564

10.1056/NEJM198108133050707

10.1136/hrt.72.4.349

Hobbs JR, Hugh-Jones K, Barrett AJ, Byron N, Chambers D, Henry K, James DC, Lucas CF, Rogers TR, Benson PF, Tansley LR, Patrick AD, Mossman J, Young EP. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone marrow transplantation. Lancet. 1981;2:709-712.

10.1056/NEJM198412203112504

10.1007/BF00798216

Gatzoulis MA, Vellodi A, Redington AN. Cardiac involvement in mucopolysaccharidoses: effect of allogenic bone marrow transplantation. Arch Dis Child. 1995;73:254-260.

10.1093/cvr/28.4.456

10.1097/00008480-199408000-00021

10.1056/NEJM199112193252501

10.1097/00045415-199301020-00006

10.1161/circ.92.5.1336

10.1093/oxfordjournals.eurheartj.a060920

10.1161/circ.91.2.541

10.1126/science.8140423

10.1172/JCI116734

10.1056/NEJM199511023331808